Vers la page d'accueil
820К+ patients ont reçu de l'aide depuis 2014
50 pays
1,500 cliniques
6K+ avis
3K+ médecins qualifiés

Quel est le Coût du Diagnostic et du Traitement de carcinomatose en Autriche ?

Le prix est donné sur demande
AutricheTurquieEspagne
Chimiothérapie intrapéritonéale hyperthermique (HIPEC)de $40,000de $22,500de $25,000
Données vérifiées par Bookimed en June 2026, sur la base des demandes des patients et des devis officiels de 64 cliniques dans le monde. Les coûts médians sont calculés à partir de factures réelles (2025–2026) et mis à jour chaque mois. Les prix réels peuvent varier.

Vos avantages et garanties avec Bookimed

Prix directs

Bookimed ne rajoute pas de frais pour les traitements de Сarcinomatose. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.

Cliniques et médecins vérifiés uniquement

Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Сarcinomatose et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.

Assistance gratuite 24/7

Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Сarcinomatose.

Pourquoi nous ?

Votre coordinateur médical personnel

  • Vous soutient à chaque étape
  • Aide à choisir la bonne clinique et le bon médecin
  • Assure un accès rapide et pratique à l'information

Découvrez les Meilleures Cliniques pour le Traitement de carcinomatose en Autriche : 1 Options Vérifiées et Prix

Le classement des cliniques Bookimed est basé sur des algorithmes de science des données, offrant une comparaison fiable, transparente et objective. Il prend en compte la demande des patients, les notes d'évaluation (positives et négatives), la fréquence des mises à jour des options de traitement et des prix, la vitesse de réponse et les certifications des cliniques.

Obtenez une évaluation médicale Сarcinomatose en en Autriche : consultez des médecins expérimentés maintenant

Voir tous les médecins
Vérifié

Wolfgang Köstler

22 années d'expérience

Le Prof. Wolfgang Köstler dirige les programmes de traitement individualisé du cancer à la Wiener Privatklinik, se spécialisant dans les thérapies ciblées pour les cancers du sein et gynécologiques.

  • Plus de 20 ans d'expérience axée sur les tumeurs malignes mammaires et gynécologiques
  • Professeur associé à l'Université de médecine de Vienne
  • Pionnier des traitements oncologiques basés sur les biomarqueurs
  • Chef adjoint de la division clinique d'oncologie à l'AKH de Vienne

Partager ce contenu

Histoires vidéo des patients de Bookimed

Dayana
J'ai combiné mes vacances à Antalya avec un bilan de santé.
Procédure: Bilan féminin
Igor
C'était génial ! Transferts, hébergement, traitement – tout était inclus.
Procédure: Implant dentaire
Clinique: WestDent Clinic
Marina
Bookimed s’est occupé de tout. Je n’avais aucun souci à me faire.
Procédure: Bilan féminin
Mis à jour: 05/27/2022
Rédigé par
Anna Leonova
Anna Leonova
Responsable de l'équipe marketing de contenu
Auteur médical certifié avec 10+ ans d'expérience, créateur des contenus fiables de Bookimed, soutenus par un Master en philologie et des interviews avec des experts médicaux internationaux.
Fahad Mawlood
Éditeur Médical et Scientifique des Données
Praticien généraliste. Lauréat de 4 prix scientifiques. Diplômé en Asie occidentale. Ancien Chef d'une équipe médicale aidant les patients arabes. Aujourd'hui responsable du traitement des données et de l'exactitude du contenu médical.
Fahad Mawlood Linkedin
Cette page peut contenir des informations relatives à diverses conditions médicales, traitements et services de santé disponibles dans différents pays. Veuillez noter que le contenu est fourni à des raisons d'information seulement et ne devrait pas être interprété comme conseil médical. Veuillez consulter votre médecin ou un professionnel de la santé qualifié avant d'entreprendre ou de changer de traitement médical.

FAQ sur le Traitement de carcinomatose en Autriche

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

What qualifies Austrian clinics as a leading destination for carcinomatosis treatment?

Austrian clinics lead in carcinomatosis treatment by integrating high-volume surgical expertise with advanced local therapies. Facilities follow strict national laws requiring multidisciplinary tumor boards and minimum procedure volumes. Specialized centers utilize hyperthermic intraperitoneal chemotherapy (HIPEC) and pressurized aerosol chemotherapy (PIPAC) to treat abdominal malignancies effectively.

  • Treatment methods: Surgeons combine complete cytoreductive surgery with heated chemotherapy for microscopic cells.
  • Specialized centers: Hanusch Hospital houses Austria’s largest surgical oncology department for peritoneal surface malignancies.
  • Expert staffing: Wiener Privatklinik features over 400 physicians, including professors from the Medical University of Vienna.
  • Quality standards: ISO certifications and Newsweek rankings validate performance indicators and patient satisfaction levels.

Bookimed Expert Insight: The structural connection between private clinics and academic institutions in Vienna provides a unique advantage. At Wiener Privatklinik, patients access senior consultants like Dr. Wolfgang Köstler, who also serves as a professor at the Medical University. This ensures that even in a private setting, the treatment logic is rooted in translational research and the latest clinical trials normally reserved for large university hospitals.

Patient Consensus: Patients note that successful outcomes depend on choosing teams with deep niche experience in complex abdominal resections. They emphasize the importance of having scans and pathology re-read by specialists before committing to aggressive surgery.

Which advanced peritoneal carcinomatosis protocols are available in Austria?

Austria offers advanced peritoneal carcinomatosis protocols including cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). These techniques treat abdominal spread from gastric, ovarian, and colorectal cancers. Medical centers follow strict guidelines to ensure high-precision surgical oncology and regional chemotherapy delivery.

  • HIPEC protocol: Heated chemotherapy is delivered intraoperatively after radical tumor resection.
  • PIPAC technique: Pressurized aerosol chemotherapy is used for patients ineligible for major surgery.
  • Digital tools: Specialized software like the Salzburg Peritoneal Surface Calculator maps disease spread.
  • Multidisciplinary boards: Cases undergo review by specialized panels to confirm surgical resectability.

Bookimed Expert Insight: Patients should prioritize centers with high surgical volumes like Wiener Privatklinik. Large institutions often have professors from the Medical University of Vienna on staff. This ensures access to the latest translational research and individualized systemic therapies. Specialist experience is the single most important factor for success in complex cytoreduction.

Patient Consensus: Patients emphasize that a diagnostic laparoscopy is often necessary because scans can underestimate disease spread. They recommend seeking second opinions at specialized peritoneal surface malignancy teams for accurate surgical evaluation.

What key criteria should I use when selecting a clinic in Austria?

Select an Austrian clinic for carcinomatosis treatment based on ISO-certified quality standards and oncological specialization. Prioritize facilities offering cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ensure the hospital features modern intensive care units and multidisciplinary tumor boards for individualized therapy planning.

  • Oncology specialization: Choose centers with dedicated international oncology departments like Wiener Privatklinik.
  • Surgical expertise: Confirm the facility performs cytoreduction and CRS-HIPEC procedures routinely.
  • Doctor credentials: Seek professors like Dr. Wolfgang Köstler with expertise in systemic therapies.
  • Accreditation status: Look for ISO certification or Newsweek World's Best Hospitals recognition.

Bookimed Expert Insight: Clinics in Vienna often centralize elite expertise by employing university professors from general hospitals. For example, top specialists at Wiener Privatklinik also hold memberships at the Medical University of Vienna. This structure allows patients to access academic-level research and targeted therapies within a private, more efficient hospital setting. This bridge between public research and private care ensures rapid access to the latest individualized treatments.

Patient Consensus: Patients emphasize finding a high-volume center where teams perform peritoneal operations daily. They note it is vital to confirm surgeons work within a dedicated malignancy team rather than general oncology.

Can I obtain an independent second opinion while in Austria?

You can obtain an independent second opinion in Austria. This country is a top destination for complex cancer reviews. Clinics like Wiener Privatklinik offer specialized services. These include interdisciplinary boards and histopathology revisions. Patients can also access remote consultations without traveling.

  • Academic expertise: Many experts are professors at the Medical University of Vienna.
  • Specialized methods: Evaluations often focus on HIPEC and cytoreductive surgery for carcinomatosis.
  • Clinical rights: Current doctors must assist by sharing your medical records and scans.
  • Diagnostic tools: Reviews include blood analysis, radiology consultations, and pathology slide re-evaluation.

Bookimed Expert Insight: The value of an Austrian second opinion lies in the affiliation with the Medical University of Vienna. Over 400 physicians at Wiener Privatklinik hold university posts. This ensures access to translational research and biomarker-led therapies. These academic links often provide treatment options not yet standard in smaller centers.

Patient Consensus: Patients emphasize that an independent review is worth the wait for advanced disease. They note that experts might change a surgery plan or suggest more conservative options. Real feedback suggests providing actual PET images and pathology slides to ensure the most accurate review.

How do I confirm that a proposed treatment is standard-of-care rather than experimental?

Confirming standard-of-care involves verifying treatments against European Society for Medical Oncology (ESMO) guidelines. A standard protocol has clear indications and known benefits. For carcinomatosis in Austria, Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an established standard for specific indications at expert oncology centers like Wiener Privatklinik.

  • Guideline status: Check if treatment appears in ESMO or NCCN clinical practice guidelines.
  • Regulatory approval: Ensure the drug or procedure has formal EMA (European Medicines Agency) clearance.
  • Evidence level: Standard treatments are supported by large-scale, randomized controlled trials (RCTs).
  • Informed consent: Experimental procedures require signing institutional research or Investigational Review Board forms.

Bookimed Expert Insight: Carcinomatosis treatment in Austria relies on highly academic affiliations to define standard-of-care. Centers like Wiener Privatklinik employ professors from the Medical University of Vienna. These specialists, including Univ. Prof. Dr. Wolfgang Köstler, lead multidisciplinary tumor boards. A consensus from such a board confirms a treatment is a recognized pathway rather than a limited institutional experiment. This academic structure ensures patients receive therapies backed by current European translational research.

Patient Consensus: Patients emphasize asking whether a treatment is a direct guideline recommendation or an off-label trial. They note that standard care must have a clear probability of benefit tied to specific cancer subtypes.

Is it possible to balance work commitments during carcinomatosis treatment in Austria?

Balancing work during carcinomatosis treatment in Austria is possible through robust legal protections and flexible reintegration models. Patients utilize Part-Time Reintegration (WIET) to reduce hours while maintaining income. Success depends on coordinating treatment cycles with specialist oncologists at accredited facilities like Wiener Privatklinik in Vienna.

  • Financial security: Employers pay 100% salary for 6 to 12 weeks during sick leave.
  • Income support: The health insurance fund provides sickness benefits for up to 78 weeks.
  • Flexible scheduling: Part-time reintegration allows working 25% to 50% hours with supplementary government pay.
  • Legal protection: Austrian framework protects oncology patients from socially unfair dismissal during active treatment.

Bookimed Expert Insight: Coordination is more efficient at private centers like Wiener Privatklinik, where many physicians are professors at the Medical University of Vienna. These specialists, such as Dr. Wolfgang Köstler, focus on individualized systemic therapies that prioritize outpatient management. Choosing clinics with high concentrations of academic experts often translates to more precise scheduling of targeted therapies. This helps patients better predict high-fatigue days and align them with professional downtime.

Patient Consensus: Patients note that sustaining a standard schedule is difficult, but focusing work on windows between chemotherapy cycles makes employment realistic. Fatigue and commuting are often bigger barriers than the medical appointments themselves, especially for those in physically demanding roles.

Obtenez une consultation gratuite

Sélectionnez la meilleure façon de vous contacter